Analystreport

Pacific Biosciences of California (NASDAQ: PACB) had its "hold" rating re-affirmed by analysts at Piper Jaffray Companies. They now have a $3.80 price target on the stock.

Pacific Biosciences of California, Inc.  (PACB) 
Last pacific biosciences of california, inc. earnings: 2/6 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.pacificbiosciences.com